Clinical Trials Logo

Outflow Tract clinical trials

View clinical trials related to Outflow Tract.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03587558 Recruiting - Clinical trials for Ventricular Premature Complexes

Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract

FOREVER
Start date: September 5, 2017
Phase: Phase 4
Study type: Interventional

Carvedilol is known to be effective in reducing ventricular arrhythmias and mortality in patients with heart failure. It is suggested that one of the mechanisms is its ability to block store overload-induced Calcium release which activates spontaneous calcium release by Ryanodine receptors. Ventricular outflow tract tachyarrhythmia is known to be associated with calcium overload due to activation of Ryanodine receptors. The aim of this study is to evaluate the efficacy of Carvedilol on premature ventricular complex(PVC)/ventricular tachycardia(VT) originating from outflow tract.